Introduction

Frank Dolan is the founder and CEO of Arsenal Advisors, which is a community of over 38,000 executive peers who work together to shape and share the best practices of the life science sector. Frank's previous work includes being a founder and leader of three pre-commercial bio from the pharmaceutical companies through which he launched over 10 new products. His strong record of increasing company value has resulted in company acquisitions by a big pharma of over $100 billion.